BPC-157 Effectively Treats Serotonin Syndrome in Rats
BPC-157 reversed serotonin syndrome symptoms (hyperthermia, tremor, agitation) in rats, demonstrating anti-serotonin-toxicity effects alongside its known dopamine and GABA system interactions.
Quick Facts
What This Study Found
BPC-157 effectively counteracted serotonin syndrome signs (hyperthermia, tremor, rigidity, agitation) induced by multiple serotonergic drugs in rats, demonstrating serotonergic system modulation complementing its known dopaminergic and GABAergic interactions.
Key Numbers
How They Did This
animal-study study on bpc-157, anxiety-mood.
Why This Research Matters
Relevant for bpc-157, anxiety-mood, neuroprotection.
The Bigger Picture
Advances peptide research with translational implications.
What This Study Doesn't Tell Us
See abstract.
Questions This Raises
- ?Further research needed.
- ?Clinical translation to evaluate.
Trust & Context
- Key Stat:
- Key finding BPC-157 effectively counteracted serotonin syndrome signs (hyperthermia, tremor, rigidity, agitation) induced by multiple serotonergic drugs in rats,
- Evidence Grade:
- preliminary evidence.
- Study Age:
- Published in 2005.
- Original Title:
- Gastric pentadecapeptide BPC 157 effective against serotonin syndrome in rats.
- Published In:
- European journal of pharmacology, 512(2-3), 173-9 (2005)
- Authors:
- Boban Blagaic, Alenka(9), Blagaic, Vladimir(5), Mirt, Mirela, Jelovac, Nikola, Dodig, Goran, Rucman, Rudolf, Petek, Marijan, Turkovic, Branko, Anic, Tomislav, Dubovecak, Miroslav, Staresinic, Mario, Seiwerth, Sven, Sikiric, Predrag
- Database ID:
- RPEP-01012
Evidence Hierarchy
Tests effects in animals (usually mice or rats), not humans.
What do these levels mean? →Frequently Asked Questions
What was studied?
BPC-157 Effectively Treats Serotonin Syndrome in Rats
What was found?
BPC-157 reversed serotonin syndrome symptoms (hyperthermia, tremor, agitation) in rats, demonstrating anti-serotonin-toxicity effects alongside its known dopamine and GABA system interactions.
Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-01012APA
Boban Blagaic, Alenka; Blagaic, Vladimir; Mirt, Mirela; Jelovac, Nikola; Dodig, Goran; Rucman, Rudolf; Petek, Marijan; Turkovic, Branko; Anic, Tomislav; Dubovecak, Miroslav; Staresinic, Mario; Seiwerth, Sven; Sikiric, Predrag. (2005). Gastric pentadecapeptide BPC 157 effective against serotonin syndrome in rats.. European journal of pharmacology, 512(2-3), 173-9.
MLA
Boban Blagaic, Alenka, et al. "Gastric pentadecapeptide BPC 157 effective against serotonin syndrome in rats.." European journal of pharmacology, 2005.
RethinkPeptides
RethinkPeptides Research Database. "Gastric pentadecapeptide BPC 157 effective against serotonin..." RPEP-01012. Retrieved from https://rethinkpeptides.com/research/boban-2005-gastric-pentadecapeptide-bpc-157
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.